Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Endocrine 1Dermatologic 1

Conditions

Colorectal Neoplasms 315Pancreatic Neoplasms 186Carcinoma, Hepatocellular 116Stomach Neoplasms 110Colonic Neoplasms 84Esophageal Neoplasms 80Carcinoma, Non-Small-Cell Lung 80Breast Neoplasms 78Rectal Neoplasms 75Ovarian Neoplasms 62Neoplasm Metastasis 59Lung Neoplasms 58Neoplasms 54Cholangiocarcinoma 53Melanoma 45Liver Neoplasms 45Gastrointestinal Neoplasms 43Prostatic Neoplasms 42Biliary Tract Neoplasms 37Endometrial Neoplasms 33Squamous Cell Carcinoma of Head and Neck 31Sarcoma 29Carcinoma, Renal Cell 29Esophageal Squamous Cell Carcinoma 27Uterine Cervical Neoplasms 26Adenocarcinoma Of Esophagus 24Head and Neck Neoplasms 23Urinary Bladder Neoplasms 22Small Cell Lung Carcinoma 20Gastrointestinal Stromal Tumors 17

Interventions

pembrolizumab 1fludarabine phosphate 1fludarabine 1Cyclophosphamide 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Microsatellite Instability × Gastrointestinal × 30 days × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT07180966 2026-05-26

SAH

Ruijin Hospital

Completed
780 enrolled
Gastrointestinal

Postoperative Complications, Stomach Neoplasms, Microsatellite Instability

NCT06004245 2026-05-08

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Vividion Therapeutics, Inc.

Phase 1 Recruiting
280 enrolled
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡